FrancophonIA/ELRC3.0 huggingface dataset:
English: - To obtain specific and exact aPTT limits, the laboratory equipment / test reagent used may be calibrated by spiking standardised human plasma with 0.15 g/ml lepirudin (lower limit) and 1.5 g/ml lepirudin (upper limit).
Danish: - For at få en specifik og præcis APTT-grænse skal det anvendte laboratorieudstyr/testreagenser kalibreres med standardiseret humanplasma tilsat 0,15 µg/ml lepirudin (nedre grænse) og 1,5 µg/ml lepirudin (øvre grænse).
English: The safety of Refludan for use in human pregnancy or lactation has not been established.
Danish: Sikkerheden omkring brug af Refludan under graviditet og amning er ikke afklaret.
English: Refludan.
Danish: opløsning.
English: Adverse events reported on Refludan are shown in the table below:
Danish: Tabellen nedenfor viser de bivirkninger, der er rapporteret for Refludan:
English: - Injection site reactions, including pain.
Danish: Reaktioner på injektionsstedet, inklusive smerte.
English: Natural hirudin is produced in trace amounts as a family of highly homologous iso-polypeptides by the leech Hirudo medicinalis.
Danish: Naturligt hirudin dannes af iglen Hirudo medicinalis i spormængder som en gruppe af meget homologe isopolypeptider.
English: * In haemodialysis patients or in case of acute renal failure (creatinine clearance below 15 ml/min or creatinine value above 60 mg/l [530 mol/l]), infusion of Refludan is to be avoided or stopped.
Danish: * Hos hæmodialysepatienter eller ved akut nyresvigt (kreatininclearance under 15 ml/min eller Skreatinin over 6 mg/l [530 mol/l)] bør infusion af Refludan undgås eller afbrydes.
English: Creatinine value [mg/l (mol/l)]
Danish: S-kreatinin [mg (mol/l)]
English: As a result all thrombin dependent coagulation assays are affected, e.g. the aPTT values increase in a dose-dependent fashion.
Danish: Som følge heraf påvirkes alle thrombin-afhængige koagulationsassay, fx stiger APTT dosisafhængigt.
English: Concomitant use with - antiplatelet agents other than acetylsalicylic acid, such as ticlopidine or clopidogrel, - GpIIb/IIIa receptor antagonists such as eptifibatide, tirofiban, or abciximab, - other thrombin inhibitors such as low molecular weight heparins has not been assessed.
Danish: Samtidig behandling med anti-blodplade stoffer udover acetylsalicylsyre, så som ticlopidin eller clopidogrel, GpIIb/IIIa receptor antagonister, så som eptifibatid, irofiban eller abciximab, Andre trombin inhibitorer, så som lav molekulær vægt hepariner er ikke blevet vurderet.
English: - Known hypersensitivity to lepirudin, to hirudins or to any of the excipients - Pregnancy and lactation (see section 4.6)
Danish: - Kendt hypersensitivitet over for hirudiner eller andre indholdsstoffer i Refludan - Graviditet og amning (se pkt.
English: (Lepirudin is a recombinant DNA product derived from yeast cells)
Danish: (Lepirudin er et DNA-recombinantprodukt fremstillet i gærceller)
English: Reported bleeding events include: anaemia or drop in the haemoglobin value without obvious source of bleeding, bruising, bleeding from puncture sites, nose bleeding, blood in urine, gastrointestinal bleeding, vaginal bleeding, rectal bleeding, pulmonary haemorrhage, bleeding into chest space and around the heart following surgery, bleeding into the brain.
Danish: Rapporteret blødningstilfælde inkluderer: Anæmi eller fald i hæmoglobin værdi uden umiddelbar blødningskilde, blå mærker, blødning fra punktur sted, næseblødning, blod i urinen, maveblødning, vaginal blødning, rektal blødning, lungeblødning, blødning i brystområdet efter en operation, blødning i hjernen.
English: In case of renal impairment relative overdose might occur even under standard dosage regimen.
Danish: - Ved nedsat nyrefunktion kan relativ overdosering indtræde selv ved standarddosering.
English: Refludan should not be administered to pregnant women or nursing mothers.
Danish: Refludan må ikke gives til gravide eller ammende mødre.
English: Please inform your doctor if you suffer from reduced kidney function or liver cirrhosis (advanced disease of the liver) for he will then reduce the dosage.
Danish: Fortæl venligst Deres læge, såfremt De lider af nedsat nyrefunktion eller skrumpelever, så vil lægen reducere dosis efter nedenstående retningslinjer.
English: Creatinine clearance [ml/min]
Danish: Kreatininclearance [ml/mm]
English: Severe bleeding and, in particular, intracranial bleeding may be fatal.
Danish: Alvorlig blødning og især hjerneblødning kan være dødelig.
English: The reconstituted solution is to be used immediately.
Danish: Den rekonstituerede opløsning skal anvendes straks.
English: [kg]
Danish: Legemsvægt [kg]
English: What Refludan is and what it is used for Before you use Refludan How to use Refludan Possible side effects 5 How to store Refludan Further information
Danish: Refludans virkning og hvad De skal bruge det til Det skal De vide, før De begynder at tage Refludan Sådan skal De tage Refludan Bivirkninger
English: If you have a bleeding tendency, your doctor will weigh the risk of Refludan administration against its benefit.
Danish: Hvis De har blødningstendens vil Deres læge nøje overveje risikoen ved Refludanbehandling i forhold til fordelen.
English: Manufacturer CSL Behring GmbH, Emil-von-Behring-Straße 76, 35041 Marburg, Germany.
Danish: Fremstiller CSL Behring GmbH, Emil-von-Behring-Straße 76, 35041 Marburg, Tyskland.
English: This particularly includes the following situations with increased bleeding risk: - Recent puncture of large vessels or organ biopsy - Anomaly of vessels or organs - Recent cerebrovascular accident, stroke, or intracerebral surgery - Severe uncontrolled hypertension - Bacterial endocarditis - Advanced renal impairment - Haemorrhagic diathesis - Recent major surgery - Recent bleeding (e.g. intracranial, gastrointestinal, intraocular, pulmonary) - Overt signs of bleeding - Recent active peptic ulcer - Age > 65 years.
Danish: Vurderingen omfatter især følgende situationer med forøgede risiko for blødning: - Nylig punktur af større blodkar eller organbiopsier - Blodkar- og organanomalier - Nylig cerebrovaskulær episode, slagtilfælde eller intracerebralt indgreb - Svær ukontrolleret hypertension - Bakteriel endocarditis - Svært nedsat nyrefunktion - Hæmorrhagisk diatese - Nylig større kirurgiske indgreb - Nylig blødning (fx intrakraniel, gastrointestinal, intraokulær, pulmonal) - Åbenlyse tegn på blødning - Nylig aktivt mavesår - Alder > 65 år.
English: What Refludan contains The active substance is lepirudin, a recombinant DNA product derived from yeast cells.
Danish: Aktivt stof: lepirudin, et rekombinant DNA-produkt afledt ud fra gærceller.
English: In elderly patients the systemic clearance of lepirudin is about 25 % lower as compared to younger patients.
Danish: Hos ældre personer er den systemiske clearance ca. 25 % lavere end hos unge voksne.
English: Do not use Refludan - if you are allergic (hypersensitive ) to lepirudin, to hirudins or any of the other ingredients of
Danish: Tag ikke Refludan - hvis De er overfølsom (allergisk) over for lepirudin, til hirudiner eller et af de øvrige indholdsstoffer hvis De er gravid eller ammer
English: Medicines given to break up clots or tablets to prevent clot formation (coumarins) may increase the risk of bleeding when given at the same time.
Danish: Blodpropnedbrydende medicin til eller tabletter til forebyggelse af blodpropper (coumariner) kan øge risikoen for blødning, hvis lægemidlerne anvendes på samme tid.
English: - For injection only polypropylene syringes may be used.
Danish: - Ikke anvendt injektionsvæske bør kasseres på passende vis. - Kun polypropylensprøjter må anvendes til injektion.
English: In intensified post-marketing surveillance in HIT type II, fatal bleeding was reported in 1 % and intracranial bleeding in 0.2 % of patients
Danish: I en intensiv post-marketingundersøgelse i HIT type II blev der rapporteret om fatal blødning hos 1 % og intrakraniel blødning hos 0,2 % af patienterne
English: - Anaphylactic/oid reactions including urticaria, difficulty in breathing (e.g. consisting of spasms), cough, sharp sound when breathing, build-up of water in the body and in the inner wall of a vessel (including: face oedema, tongue oedema, throat oedema).
Danish: Anafylaktiske reaktioner inklusive nældefeber, åndenød, med krampeagtige anfald, hoste, skarp åndelyd, vand i kroppen og i indervæggen af karrene (inklusive ansigtsødem, tungeødem, halsødem).
English: Anticoagulation in adult patients with HIT type II and thromboembolic disease:
Danish: Antikoagulationsbehandling af patienter med type II HIT og thromboembolisk sygdom:
English: Refludan is used for anticoagulation in adult patients with heparin-induced thrombocytopenia (HIT) type II and thromboembolic disease requiring injected antithrombotic medicines.
Danish: Refludan anvendes til antikoagulation (hæmning af blodpropdannelse) hos voksne patienter med heparin-induceret trombocytopeni (blodplademangel) type II HIT samt tromboembolisk sygdom (blodpropper), som kræver injiceret antithrombotisk medicin.
English: Anticoagulation in adult patients with heparin-induced thrombocytopenia (HIT) type II and thromboembolic disease mandating parenteral antithrombotic therapy.
Danish: Antikoagulation hos voksne patienter med type II heparin-induceret thrombocytopeni (HIT) og thromboembolisk sygdom, hvor parenteral antitrombotisk behandling er indiceret.
English: VIAL LABEL: 50 mg
Danish: Hætteglas etiket 50 mg
English: VIAL LABEL: 20 mg
Danish: Hætteglas etiket 20 mg
English: The speed of the perfusor automate [ml per hour] is to be set in a body weight dependent fashion.
Danish: Perfusionsautomatens infusionshastighed [ml pr. time] skal sættes i relation til legemsvægten.
English: Urticaria
Danish: Hæmaturia
English: As lepirudin is almost exclusively excreted and metabolised renally (see also section 5.2), the patient's renal function should be considered prior to administration.
Danish: Da lepirudin næsten udelukkende udskilles og metaboliseres renalt (se også pkt.
English: - Target range (therapeutic window) for the aPTT: - Using "Actin FS" or "Neothromtin" on automated coagulometers the target range for the aPTT is 1.5 fold to 3 fold prolongation of the normal control value.
Danish: - Målintervallet (det terapeutiske vindue) for APTT: - Målintervallet for APTT er en 1,5-3 gange forlængelse af den normale kontrolværdi, når der til kontrollen bruges "Actin FS" eller "Neothromtin" i automatiserede koagulometre.
English: In intensified post-marketing surveillance in HIT type II, fatal bleeding was reported in 1 % and intracranial bleeding in 0.2 % of patients.
Danish: I et intensivt postmarketing undersøgelse i HIT type II, blev dødelig blødning rapporteret i 1% og blødning i hjernen i 0,2 % af patienterne.
English: Only if aPTT values have fallen below the lower therapeutic limit (see Monitoring: target range), further intravenous bolus doses of 0.1 mg / kg body weight may be considered every other day.
Danish: Kun såfremt APPT ligger under den øvre terapeutiske grænse (se Monitorering: målinterval), kan yderligere i.v.
English: Thus, please tell your doctor if you have or have had: - Recent puncture of large vessels or organs - Anomaly of vessels or organs - Recent stroke, accident or surgery involving the brain - High blood pressure - Inflammation of the inner membrane of the heart - Advanced kidney disease - Advanced bleeding tendency - Recent major surgery
Danish: Informer derfor venligst Deres læge specielt om følgende: - Nylig punktur af større blodkar eller organer - Misdannelser af blodkar og organer - Nylig slagtilfælde, ulykker eller operationer, som medinddrager hjernen - Forhøjet blodtryk - Bakterieinfektion i hjerteklapperne og hjertets indre hinde - Svær nedsat nyrefunktion.
English: Therefore, the bolus dose and infusion rate must be reduced in case of known or suspected renal insufficiency (creatinine clearance below 60 ml/min or creatinine value above 15 mg/l [133 mol/l]).
Danish: Derfor bør bolusdosen og infusionshastigheden reduceres ved kendt eller ved mistanke om nyreinsufficiens (kreatininclearance under 60 ml/min.
English: Presentations: - Pack with 1 vial - Pack with 10 vials Not all pack sizes may be marketed.
Danish: Pakninger: - Pakning 1 hætteglas - Pakning med 10 hætteglas.
English: - 0.4 mg / kg body weight intravenously as a bolus dose - followed by 0.15 mg / kg body weight / hour as a continuous intravenous infusion for 2 - 10
Danish: som bolusdosis - efterfulgt af 0,15 mg / kg legemsvægt / time som kontinuerlig intravenøs infusion i 2 - 10 dage eller længere afhængigt af det kliniske behov.
English: The rate of infusion must be reduced in case of known or suspected renal insufficiency (see sections 4.2, and 5.2).
Danish: Infusionshastigheden skal reduceres ved kendt eller ved mistanke om nyreinsufficiens (se pkt.
English: Keep the -vial in the outer carton.
Danish: Opbevar hætteglasset i den originale yderpakning.
English: Dosage 0.2 mg / kg body weight
Danish: Dosis 0,1 mg / kg legemsvægt/time
English: Bleeding from puncture sites
Danish: Blødning fra injektionssteder Epistaksis
English: For continuous intravenous infusion, a solution with a concentration of 2 mg/ml is needed.
Danish: Til kontinuerlig intravenøs infusion anvendes en opløsning med styrken 2 mg/ml.
English: - The final solution is to be administered in a body weight-dependent fashion (see section 4.2).
Danish: - Den færdige opløsning doseres i henhold til legemsvægten (se 4.2).
English: For intravenous bolus injection, a solution with a concentration of 5 mg/ml is needed.
Danish: Til intravenøs bolus injektion anvendes en opløsning med styrken 5 mg/ml.
English: - Recent bleeding (e.g. in brain, stomach/intestine, eye, lung) - Obvious signs of bleeding - Recent active peptic ulcer - Age > 65 years
Danish: Åbenlyse tegn på blødning - Nylig aktivt mavesår - Alder > 65 år.
English: - For rapid, complete reconstitution, inject 0.4 ml of diluent into the vacuum vial and shake it gently.
Danish: - Ønskes hurtig rekonstituering injiceres 0,4 ml solvens i vacuumhætteglasset, som derefter omrystes forsigtigt.
English: EU/1/97/035/001 REFLUDAN - 50 mg - Powder for solution for injection or infusion - 1 vial EU/1/97/035/002 REFLUDAN - 50 mg - Powder for solution for injection or infusion - 10 vials
Danish: EU/1/97/035/002 REFLUDAN - 50 mg - pulver til infusionsvæske eller infusionsvæske, opløsning10 hætteglas
English: EU/1/97/035/003 REFLUDAN - 20 mg - Powder for solution for injection or infusion - 1 vial EU/1/97/035/004 REFLUDAN - 20 mg - Powder for solution for injection or infusion - 10 vials
Danish: EU/1/97/035/004 REFLUDAN - 20 mg - pulver til infusionsvæske eller infusionsvæske, opløsning10 hætteglas
English: Any unused solution must be discarded appropriately.
Danish: Bortskaf ubrugt opløsning på passende måde.
English: - For reconstitution water for injections or sodium chloride 9 mg/ml (0.9 %) solution are to be used.
Danish: - Refludan rekonstitueres med sterilt vand eller natriumchlorid 9 mg/ml (0,9%) opløsning.
English: - The final concentration of 2 mg/ml is obtained by transfer of both solutions into one sterile,
Danish: - Styrken 2 mg/ml fås ved at overføre begge opløsninger til en steril engangsperfusionssprøjte (50
English: On reconstitution a clear, colourless solution is usually obtained within less than
Danish: Ved rekonstituering fås en klar, farveløs injektionsvæske inden for 3
English: Refludan should therefore not be administered to pregnant women or nursing mothers.
Danish: Refludan må derfor ikke anvendes ved graviditet og amning.
English: - For rapid, complete reconstitution, inject 1 ml of diluent into the vacuum vial and shake it gently.
Danish: - Ønskes hurtig rekonstituering injiceres 1 ml solvens i vacuumhætteglasset, som derefter omrystes forsigtigt.
English: Dosage 0.15 mg / kg body weight / h Dosage 0.1 mg / kg body weight / h
Danish: Injektionsvolumen [ml] Dosis 0, 4 mg / kg legemsvægt Dosis 0, 2 mg / kg legemsvægt
English: OUTER CARTON: 20 mg x 10 vials
Danish: Ydre karton: 20 mg x 10 hætteglas
English: Injection vial:
Danish: Oversigt over indlægssedlen:
English: Angio-oedema (including: face oedema, tongue oedema, larynx oedema)
Danish: Angioødem (inklusiv: ansigtsødem, tungeødem, larynksødem)
English: OUTER CARTON: 50 mg x 10 vials
Danish: Ydre karton: 50 mg x 10 hætteglas
English: OUTER CARTON: 20 mg x 1 VIAL
Danish: Ydre karton: 20 mg x 1 hætteglas
English: OUTER CARTON: 50 mg x 1 VIAL
Danish: Ydre karton: 50 mg x 1 hætteglas
English: 1 vial contains 20 mg lepirudin.
Danish: Et hætteglas indeholder 20 mg lepirudin.
English: Each vial contains 50 mg lepirudin.
Danish: Hver hætteglas indeholder 50 mg lepirudin.
English: HOW TO STORE REFLUDAN
Danish: Refludans udseende og pakningstørrelse
English: Reconstitute one vial (20 mg of lepirudin) with 0.4 ml of either water for injections or sodium chloride 9 mg/ml (0.9 %) solution.
Danish: 1 hætteglas (20 mg lepirudin) rekonstitueres med enten 0,4 ml vand til injektionsvæsker eller natriumchlorid 9 mg/ml (0,9%), opløsning.
English: BEFORE YOU USE REFLUDAN
Danish: DET SKAL DE VIDE, FØR DE BEGYNDER AT TAGE REFLUDAN
English: Powder for solution for injection or infusion.
Danish: Pulver til injektionsvæske og infusionsvæske opløsning.
English: - The infusion speed of the perfusor automate is to be set in a body weight-dependent fashion.
Danish: - Perfusionsautomatens infusionshastighed justeres i henhold til legemsvægten.
English: 1 vial contains 50 mg lepirudin.
Danish: Et hætteglas indeholder 50 mg lepirudin.
English: In monkeys retinal haemorrhages occurred.
Danish: Hos aber sås blødninger i retina.
English: Reconstitute one vial (50 mg of lepirudin) with 1 ml of either water for injections or sodium chloride 9 mg/ml (0.9 %) solution.
Danish: 1 hætteglas (50 mg lepirudin) rekonstitueres med enten 1 ml vand til injektionsvæsker eller natriumchlorid 9 mg/ml (0,9%), opløsning.
English: - For further dilution sodium chloride 9 mg/ml (0.9 %) or glucose 5 % solutions are suitable.
Danish: og herefter yderligere fortynde med natriumchlorid 9 mg/ml (0,9%) opløsning eller 5 %
English: mg/ml (0.9 %) or glucose 5 % solution.
Danish: (0,9%) eller 5 % glucoseinfusionsvæske.
English: - If any of the side effects gets serious, or if you notice side effects not listed in this leaflet,
Danish: - Tal med lægen eller apoteket, hvis en bivirkning bliver værre, eller De får bivirkninger, som ikke er nævnt her.
English: Preparation of a Refludan solution with a concentration of 5 mg/ml For intravenous.
Danish: Fremstilling af Refludan injektionsvæske 5 mg/ml
English: Refludan 20 mg powder for solution for injection or infusion Lepirudin
Danish: Refludan, 20 mg pulver til injektion eller infusion Lepirudin
English: - The final solution is to be administered in a body weight-dependent fashion.
Danish: - Den færdige opløsning doseres i henhold til legemsvægten.
English: 10 x 1 vial of powder for solution for injection or infusion.
Danish: 10 hætteglas med pulver til injektionsvæske eller infusionsvæske, opløsning.
English: - Do not use solutions which are cloudy or contain particles.
Danish: - Uklare injektionsvæsker eller injektionsvæsker, der indeholder partikler, må ikke anvendes.
English: - This medicine has been prescribed for you.
Danish: - Lægen har ordineret Lepirudin til Dem personligt.
English: Refludan 50 mg powder for solution for injection or infusion Lepirudin
Danish: Refludan 50 mg pulver til injektion eller infusion, opløsning lepirudin
English: Refludan 20 mg powder for solution for injection or infusion lepirudin
Danish: Refludan 20 mg pulver til injektion eller infusion, opløsning Lepirudin
English: single-use perfusor syringe (50 ml capacity) and further dilution to a total volume of 50 ml using sodium chloride 9 mg/ml (0.9 %) or glucose 5 % solution.
Danish: ml sprøjte) og herefter yderligere fortynde med natriumchlorid 9 mg/ml (0,9%) opløsning eller 5
English: Refludan 50 mg powder for solution for injection or infusion
Danish: Refludan 50 mg pulver til injektionsvæske og infusionsvæske, opløsning
English: - The final concentration of 5 mg/ml is obtained by transfer into a sterile, single-use syringe (of at least 10 ml capacity) and further dilution to a total volume of 10 ml using sodium chloride
Danish: opløsning - Styrken 5 mg/ml fås ved at overføre opløsningen til en steril engangssprøjte (min. 10 ml sprøjte)
English: - The final concentration of 5 mg/ml is obtained by transfer into a sterile, single-use syringe (of at least 5 ml capacity) and further dilution to a total volume of 4 ml using sodium chloride
Danish: opløsning - Styrken 5 mg/ml fås ved at overføre opløsningen til en steril engangssprøjte (min. 5 ml sprøjte)
English: 1 vial of powder for solution for injection or infusion.
Danish: 1 hætteglas med pulver til injektionsvæske eller infusionsvæske, opløsning.
English: The base system is in place.
Danish: Det grundlæggende system er på plads.
English: Total Recalls Class 1 Class 2 Class 3
Danish: I alt Tilbagekaldelser Klasse 1 Klasse 2 Klasse 3
English: 6.3 Personnel
Danish: 6.3 Personale
English: Companies' interest in the SME initiative exceeded expectations.
Danish: Virksomhedernes interesse for SMV-initiativet oversteg forventningerne.
English: Adoption of several proposals for greater transparency.
Danish: Vedtagelse af flere forslag om større åbenhed.
English: The SME Office provided regulatory assistance to 14 companies.
Danish: SMV-kontoret ydede forskriftsmæssig bistand til 14 virksomheder.
English: Special financial support from the EU budget
Danish: Særlig finansiel støtte fra EU-budgettet
English: Both procedures are based upon the principle of recognition of national authorisations.
Danish: Begge procedurer er baseret på princippet om gensidig anerkendelse af nationale godkendelser.
English: 2.8 Parallel distribution
Danish: 2.8 Paralleldistribution
English: Adoption of the Agency's work programme, establishment plan and budget for 2007.
Danish: Vedtagelse af agenturets arbejdsprogram, stillingsfortegnelse og budget for 2007.
English: 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel. (44-20) 74 18 84 00 Fax (44-20) 74 18 84 09 E-mail: mail@emea.europa.eu http://www.emea.europa.eu
Danish: 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tlf.: (44-20) 74 18 84 00 Fax (44-20) 74 18 84 09 E-mail: mail@emea.europa.eu http://www.emea.europa.eu
English: Notably, the Agency finalised safety reviews of:
Danish: Det skal især nævnes, at agenturet afsluttede sikkerhedsundersøgelser af:
English: Regulation (EC) No 1901/2006 on medicinal products for paediatric use.
Danish: Forordning (EF) nr. 1901/2006 om lægemidler til pædiatrisk brug.
English: Main initiatives of this new framework:
Danish: De vigtigste initiativer i disse nye rammebestemmelser er:
English: An annual management review was conducted, aimed at ensuring that management tools are effective and suitable.
Danish: Der blev foretaget en årlig ledelsesrevision, som har til formål at sikre, at ledelsesværktøjerne er effektive og hensigtsmæssige.
English: The scientific advice procedure has been improved and is used increasingly by sponsors of medicinal products.
Danish: Den videnskabelige rådgivningsprocedure er blevet forbedret og benyttes i stigende grad af sponsorer af lægemidler.
English: Although these generic medicines are not innovative, they are considered to represent an important contribution to public health in the EU.
Danish: Selv om disse generiske lægemidler ikke er innovative, betragtes de alligevel som et vigtigt bidrag til folkesundheden i EU.
English: Before I come to the end, I would like to commemorate our dear friend and Management Board colleague, Professor Gianmartino Benzi, who passed away in November 2006.
Danish: Inden jeg afslutter, vil jeg gerne benytte mig af lejligheden til at mindes vores kære ven og bestyrelseskollega, professor Gianmartino Benzi, som døde i november 2006.
English: His spirit, his enthusiasm and his contributions to the work of the European Medicines Agency are greatly missed.
Danish: Hans ånd, hans entusiasme og hans store bidrag til arbejdet i Det Europæiske Lægemiddelagentur er dybt savnet.